You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study

Citation Tools

Article menu
Psoriatic arthritis
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gossec L, Siebert S, Bergmans P, et al
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
Annals of the Rheumatic Diseases 2023;82:496-506.